» Articles » PMID: 28842210

Racial or Ethnic and Socioeconomic Disparities in Prostate Cancer Survivors' Prostate-specific Quality of Life

Overview
Journal Urology
Specialty Urology
Date 2017 Aug 27
PMID 28842210
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To conduct a prospective study to examine whether there are pretreatment and post-treatment disparities in urinary, sexual, and bowel quality of life (QOL) by race or ethnicity, education, or income in men with clinically localized prostate cancer (PCa.) METHODS: Participants (N = 1508; 81% white; 12% black; 7% Hispanic; 50% surgery; 27% radiotherapy; 23% active surveillance) completed the Expanded Prostate Cancer Index Composite measure of PCa-specific QOL prior to treatment, 6 weeks, 6, 12, 18, and 24 months after treatment. We analyzed pretreatment differences in QOL with multivariable linear regression and post-treatment differences with generalized estimating equation models.

Results: Blacks and Hispanics (compared with whites) and men with lower income had worse pretreatment urinary function; poorer and less educated men had worse pretreatment sexual function (P < .05). In adjusted models, among men treated surgically, blacks and Hispanics had worse bowel function compared with whites, and men with lower income experienced more sexual bother and slower recovery in urinary function. Not all racial or ethnic differences favored whites; blacks had higher sexual function than whites prior to surgery and improved faster after surgery. Blacks receiving radiotherapy had lower post-treatment bowel bother than whites (P < .05).

Conclusion: Controlling for baseline QOL, there were some post-treatment disparities in urinary and sexual QOL that suggest the need to investigate whether treatment quality and access to follow-up care is equitable. However, survivorship disparities may, to a greater extent, reflect disadvantages in baseline health that exacerbate QOL issues after treatment.

Citing Articles

Bridging the Gap: Enhancing Prostate Cancer Survivorship and Advocacy Among Ethnically Diverse Black Men Through Community Town Halls.

Ogunsanya M, Kaninjing E, DeForge S, Morton D, Cole P, Beckford P J Cancer Educ. 2025; .

PMID: 39994169 DOI: 10.1007/s13187-025-02587-1.


Association between smoking and prostate cancer survivors' long-term quality of life and function: an analysis of the CEASAR (Comparative Effectiveness Analysis of Surgery and Radiation) study.

Nguyen D, Barocas D, Zhao Z, Huang L, Koyama T, Al Hussein Ai Awamlh B J Cancer Surviv. 2024; .

PMID: 39400687 DOI: 10.1007/s11764-024-01692-2.


Application of Geographic Information Systems (GIS) in the Study of Prostate Cancer Disparities: A Systematic Review.

El Khoury C Cancers (Basel). 2024; 16(15).

PMID: 39123443 PMC: 11312136. DOI: 10.3390/cancers16152715.


Comparison of Medical Research Abstracts Written by Surgical Trainees and Senior Surgeons or Generated by Large Language Models.

Holland A, Lorenz W, Cavanagh J, Smart N, Ayuso S, Scarola G JAMA Netw Open. 2024; 7(8):e2425373.

PMID: 39093561 PMC: 11297395. DOI: 10.1001/jamanetworkopen.2024.25373.


Racial and socioeconomic disparities in surgical care for post-prostate cancer treatment complications: A nationwide Medicare-based analysis.

Adesanya O, Rojanasarot S, McGovern A, Burnett A BJUI Compass. 2024; 5(6):564-575.

PMID: 38873355 PMC: 11168770. DOI: 10.1002/bco2.342.


References
1.
Ramsey S, Zeliadt S, Hall I, Ekwueme D, Penson D . On the importance of race, socioeconomic status and comorbidity when evaluating quality of life in men with prostate cancer. J Urol. 2007; 177(6):1992-9. DOI: 10.1016/j.juro.2007.01.138. View

2.
Gaskin D, Thorpe Jr R, McGinty E, Bower K, Rohde C, Young J . Disparities in diabetes: the nexus of race, poverty, and place. Am J Public Health. 2013; 104(11):2147-55. PMC: 4021012. DOI: 10.2105/AJPH.2013.301420. View

3.
Lubeck D, Kim H, Grossfeld G, Ray P, Penson D, Flanders S . Health related quality of life differences between black and white men with prostate cancer: data from the cancer of the prostate strategic urologic research endeavor. J Urol. 2001; 166(6):2281-5. View

4.
Shamloul R, Ghanem H . Erectile dysfunction. Lancet. 2012; 381(9861):153-65. DOI: 10.1016/S0140-6736(12)60520-0. View

5.
Calixto O, Anaya J . Socioeconomic status. The relationship with health and autoimmune diseases. Autoimmun Rev. 2014; 13(6):641-54. DOI: 10.1016/j.autrev.2013.12.002. View